Direct Oral Anticoagulants Versus Vitamin K Antagonist in Elderly Patients With Atrial Fibrillation: Sometimes Less Is More, but Sometimes More Is More

Benzer Materyaller

• Uptake of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation – a prospective cohort study
  Yazar:: Matylda Zimny, ve diğerleri
  Baskı/Yayın Bilgisi: (2017-02-01)
• Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants
  Yazar:: Jo-Nan Liao, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-07-01)
• Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
  Yazar:: Anetta Undas, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-12-01)
• Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program
  Yazar:: Rabih R. Azar, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-06-01)
• Non-Vitamin K Oral Anticoagulants Assessment in High Risk of Bleeding Patients with Non-Valvular Atrial Fibrillation
  Yazar:: Pedro Silva Cunha, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-02-01)